Press-release for stocks related to pharma for evok

Prices are updated after-hours

tags : Pharma symbols : Evok

save search

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis
Published: 2024-04-17 (Crawled : 15:00) - biospace.com/
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| Email alert Add to watchlist
pharma key

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| Email alert Add to watchlist
pharma key

Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
Published: 2024-03-21 (Crawled : 20:00) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -20.34% | O: 0.83% H: 4.45% C: 1.19%
pharma

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 20:00) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -30.33% | O: -4.68% H: 5.88% C: -3.58%
pharma year financial results

Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -32.37% | O: 1.29% H: 2.27% C: -0.57%
pharma report year results

Evoke Pharma Announces Closing of $7.5 Million Public Offering
Published: 2024-02-14 (Crawled : 12:30) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -30.24% | O: -3.52% H: 9.23% C: 8.66%
pharma million offering

Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
Published: 2024-02-09 (Crawled : 12:30) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -26.85% | O: -0.39% H: 17.19% C: 16.41%
pharma million offering

Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent
Published: 2023-11-27 (Crawled : 13:30) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -62.4% | O: 0.0% H: 10.52% C: 4.0%
fda pharma patent gimoti

Evoke Pharma Reports Third Quarter 2023 Financial Results
Published: 2023-11-09 (Crawled : 13:30) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -59.48% | O: -0.86% H: 15.65% C: 11.3%
pharma financial results

Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023
Published: 2023-10-31 (Crawled : 13:00) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -58.77% | O: 4.4% H: 1.6% C: -2.54%
pharma gimoti eversana

Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI®
Published: 2023-09-14 (Crawled : 12:30) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -53.47% | O: 7.92% H: 1.83% C: -3.67%
gimoti pharma

Evoke Pharma Reports Second Quarter 2023 Financial Results
Published: 2023-08-10 (Crawled : 12:20) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -65.94% | O: 1.09% H: 3.94% C: 1.08%
pharma financial results

Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) Meeting
Published: 2023-08-07 (Crawled : 12:20) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -69.28% | O: 0.0% H: 0.0% C: -7.84%
pharma eversana meeting

Evoke Pharma and EVERSANA Announce Abstract Selection for Plenary Oral Presentation at The American College of Gastroenterology (ACG) 2023 Annual Meeting
Published: 2023-07-25 (Crawled : 12:00) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -72.31% | O: -0.37% H: 1.71% C: -2.13%
pharma eversana presentation meeting

Evoke Pharma to Host First Key Opinion Leader Webinar on Healthcare Resource Utilization Data Related to Gastroparesis and its Treatment
Published: 2023-06-14 (Crawled : 12:00) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -73.89% | O: 5.0% H: 0.0% C: -13.76%
pharma treatment

Evoke Pharma Reports First Quarter 2023 Financial Results
Published: 2023-05-15 (Crawled : 20:00) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -75.6% | O: 3.85% H: 0.0% C: -6.0%
pharma financial results

Real-World Data Presented by Evoke Pharma and EVERSANA at Digestive Disease Week 2023 Shows Gimoti® Meaningfully Reduces Utilization of Healthcare Resources
Published: 2023-05-09 (Crawled : 11:00) - globenewswire.com
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -78.89% | O: 7.15% H: 0.58% C: -5.7%
gimoti pharma disease week

United States Patent and Trademark Office (USPTO) Grants Evoke Pharma a Formulation Patent Covering GIMOTIThe Company Will Submit for FDA Orange-Book Listing in the Near Term
Published: 2023-04-20 (Crawled : 14:20) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K

Communications

| -13.65% | O: -0.47% H: 0.0% C: 0.0%
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -77.62% | O: 15.24% H: 0.0% C: -11.57%
fda pharma patent grants

Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI-Related Patent
Published: 2023-04-06 (Crawled : 13:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 34K

Communications

| -10.61% | O: -0.36% H: 0.0% C: 0.0%
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology

| -75.77% | O: 0.51% H: 5.64% C: 3.59%
pharma patent

Evoke Pharma Reports Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-03-21 (Crawled : 22:00) - biospace.com/
EVOK | News | $0.489 -10.93% -12.27% 21K

Health Technology